The Master Antioxidant

How glutathione works as the body's primary defense against oxidative stress, why levels decline with age, and what the research says about supplementation

Glutathione is a small protein your body makes in every cell — and it may be the most important antioxidant you've never heard of. Often called the "master antioxidant," it neutralizes free radicals, regenerates other antioxidants like vitamins C and E, and supports liver detoxification. The problem is that glutathione levels drop with age, chronic illness, poor diet, and toxic exposure — at precisely the times when you need it most. A six-month clinical trial found that daily oral supplementation raised blood glutathione levels by 17–35% and more than doubled natural killer cell activity [1].

How Glutathione Works

Glutathione (GSH) is a tripeptide made from three amino acids: glutamine, glycine, and cysteine. It exists in almost every cell in the body, with the highest concentrations in the liver. Its job is to neutralize reactive oxygen species (free radicals) before they damage DNA, proteins, and cell membranes — and then it gets recycled and used again.

Beyond direct antioxidant activity, glutathione:

Regenerates other antioxidants. It restores oxidized vitamin C and vitamin E back to their active forms, multiplying their effectiveness.
Supports Phase II liver detoxification. The liver uses glutathione to conjugate and excrete heavy metals, pesticides, and drug metabolites. Low GSH means reduced detox capacity.
Regulates immune signaling. Glutathione modulates T-cell proliferation and natural killer cell activity, helping calibrate both innate and adaptive immunity.
Maintains mitochondrial function. Mitochondria generate significant oxidative byproducts and are heavily dependent on adequate glutathione levels to remain functional.

Why Levels Decline

Glutathione production requires cysteine, which is often the rate-limiting building block. Levels fall with:

Age — older adults typically have 30–50% lower GSH than young adults [4]
Chronic inflammation or illness — elevated oxidative load depletes stores faster than the body replenishes them
Toxic exposures — alcohol, heavy metals, acetaminophen, and pesticides all consume GSH during detoxification
Poor diet — low intake of sulfur-rich foods (meat, eggs, onions, garlic) limits cysteine supply
Intense exercise without recovery — acute demand without adequate nutrition

Supplementation: Forms and Bioavailability

For years, experts doubted whether oral glutathione could survive digestion intact. That view has been updated by clinical data. A rigorous six-month RCT found dose-dependent increases in blood and tissue GSH following oral supplementation [1]. However, form matters:

Reduced GSH (standard oral): Moderately effective; 250–1,000 mg/day raises blood levels meaningfully over 1–3 months [1].
Sublingual GSH: A crossover study found sublingual delivery significantly outperformed standard oral GSH and NAC for raising the GSH/GSSG (reduced/oxidized) ratio and improving oxidative stress markers [2].
Liposomal GSH: Encapsulating glutathione in phospholipid particles protects it from gut degradation and improves cellular uptake [3].
GlyNAC (precursor approach): Supplementing glycine and NAC together replenishes both building blocks, allowing the body to synthesize its own GSH — a strategy shown to correct glutathione deficiency in older adults [4].

Practical Use

Typical doses used in research: 250–1,000 mg/day for standard oral; lower doses (50–300 mg) for sublingual or liposomal forms. Take on an empty stomach. Supplement with vitamin C, which works synergistically with glutathione. NAC (N-acetylcysteine) is a cost-effective alternative for those who primarily want to support GSH production rather than supplement it directly.

See our NAC page for more on the precursor approach. For liver support, see our Milk Thistle page and Liver Cleansing page.

Evidence Review

Bioavailability: Oral GSH Does Raise Tissue Levels

The landmark study on oral glutathione bioavailability (Richie et al., 2015; PMID 24791752) enrolled 54 healthy non-smoking adults in a six-month, double-blind, placebo-controlled RCT [1]. Participants received placebo, 250 mg/day (low dose), or 1,000 mg/day (high dose) of reduced glutathione.

Results were significant:

High-dose group: 30–35% increase in erythrocyte, plasma, and lymphocyte GSH; 260% increase in buccal cell GSH
Low-dose group: 17–29% increases in erythrocyte and plasma GSH
Natural killer (NK) cell cytotoxicity increased more than 2-fold in the high-dose group at 3 months versus placebo
The oxidized-to-reduced GSH ratio decreased, confirming genuine antioxidant activity, not just passive accumulation
After a one-month washout, levels returned to baseline — confirming the supplementation was driving the changes

This dispelled the long-held assumption that dietary glutathione is entirely destroyed in digestion.

Sublingual vs. Oral vs. NAC: A Head-to-Head Comparison

Schmitt et al. (2015; PMID 26262996) conducted a three-arm crossover trial in 20 adults with metabolic syndrome [2]. Each participant cycled through 21-day periods of NAC, standard oral GSH, and sublingual GSH. Key findings:

Sublingual GSH produced a significantly higher GSH/GSSG ratio than oral GSH (p = 0.003)
Only the sublingual group showed meaningful plasma vitamin E elevation (0.83 µmol/g; p = 0.04), reflecting downstream antioxidant regeneration
Oral GSH and NAC both improved markers, but sublingual delivery had superior bioavailability
Limitations: small sample (n=20), crossover design with relatively short washout periods; metabolic syndrome population may not generalize

Liposomal GSH and Immune Function in Diabetes

To et al. (2021; PMID 34150674) tested liposomal oral glutathione in people with type 2 diabetes — a population known for chronically low GSH [3]. The 3-month RCT found:

Significant reduction in oxidative stress across all blood fractions
Reduced intracellular mycobacterial burden (a measure of immune competence)
Increased Th1 cytokines (IFN-γ, TNF-α, IL-2) that drive pathogen clearance
Decreased pro-inflammatory IL-6 and IL-10
Authors characterized liposomal GSH as a potential "host-directed therapy" for individuals with impaired immune function

This study is notable because type 2 diabetes is one of the most common conditions associated with glutathione depletion, and the immune improvements were clinically meaningful.

GlyNAC for Aging: Correcting Glutathione Deficiency at the Root

Kumar et al. (2023; PMID 35975308) published a 16-week RCT of GlyNAC (combined glycine + N-acetylcysteine) supplementation in 24 older adults [4]. Compared to young adult controls, older adults at baseline showed measurable glutathione depletion, elevated oxidative stress, mitochondrial dysfunction, systemic inflammation, insulin resistance, and reduced physical capacity. After 16 weeks of GlyNAC:

Glutathione deficiency was fully corrected
Oxidative stress markers normalized
Mitochondrial fatty-acid oxidation improved
Inflammatory biomarkers decreased
Physical measures improved: gait speed, muscle strength, and 6-minute walk distance increased
Endothelial function improved

The placebo group showed none of these changes. This study is particularly compelling because it addresses the mechanism — aging-related glutathione decline — rather than just supplementing the molecule directly.

Skin and Antiaging Effects

Weschawalit et al. (2017; PMID 28490897) conducted a 12-week RCT in healthy female subjects comparing reduced GSH (250 mg/day), oxidized GSH (GSSG, 250 mg/day), and placebo [5]:

Both GSH and GSSG groups showed significantly reduced melanin index and UV spots versus placebo
The reduced GSH group showed significant reduction in wrinkles at assessed sites
Trend toward increased skin elasticity in both supplementation groups
No serious adverse effects were observed in any group

Both forms of oral glutathione were effective at influencing skin properties, suggesting the antiaging effects go beyond simple antioxidant activity.

Strength of Evidence

The overall evidence base is growing and encouraging, but worth calibrating:

Bioavailability is now well-established for oral, sublingual, and liposomal forms [1][2]
Immune and antioxidant effects have solid RCT support in specific populations (diabetics, older adults) [3][4]
Long-term health outcomes (disease prevention, longevity) have not yet been established in large trials
Most studies involve specific populations (metabolic syndrome, type 2 diabetes, older adults) rather than healthy young adults
The GlyNAC precursor approach currently has arguably the strongest evidence for reversing aging-related GSH decline [4]

For otherwise healthy individuals, glutathione supplementation appears safe and likely beneficial for maintaining antioxidant status — especially as a complement to a diet rich in sulfur-containing foods, adequate protein, and NAC.

References

Randomized Controlled Trial of Oral Glutathione Supplementation on Body Stores of GlutathioneRichie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE. European Journal of Nutrition, 2015. PubMed 24791752 →
Effects of N-acetylcysteine, Oral Glutathione (GSH) and a Novel Sublingual Form of GSH on Oxidative Stress Markers: A Comparative Crossover StudySchmitt B, Vicenzi M, Garrel C, Denis FM. Redox Biology, 2015. PubMed 26262996 →
Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 DiabetesTo K, Cao R, Yegiazaryan A, Owens J, Nguyen T, Sasaninia K, Vaughn C, Singh M, Truong E, Medina A, Avitia E, Villegas J, Pham C, Sathananthan A, Venketaraman V. Frontiers in Cellular and Infection Microbiology, 2021. PubMed 34150674 →
Supplementing Glycine and N-Acetylcysteine (GlyNAC) in Older Adults Improves Glutathione Deficiency, Oxidative Stress, Mitochondrial Dysfunction, Inflammation, Physical Function, and Aging Hallmarks: A Randomized Clinical TrialKumar P, Liu C, Suliburk J, Hsu JW, Muthupillai R, Jahoor F, Minard CG, Taffet GE, Sekhar RV. Journals of Gerontology: Biological Sciences and Medical Sciences, 2023. PubMed 35975308 →
Glutathione and Its Antiaging and Antimelanogenic EffectsWeschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Clinical, Cosmetic and Investigational Dermatology, 2017. PubMed 28490897 →